Abstract
ErbB4 has emerged as a leading susceptibility gene for schizophrenia but the function of the ErbB4 receptor in the adult brain is unknown. Here, we show in the adult hippocampus that long-term potentiation (LTP) of transmission at Schaffer collateral CA1 synapses was markedly enhanced in mutant mice lacking ErbB4. Concordantly, LTP was enhanced by acutely blocking ErbB4 in wild-type animals, indicating that ErbB4 activity constitutively suppresses LTP. Moreover, increasing ErbB4 signaling further suppressed LTP. By contrast, altering ErbB4 activity did not affect basal synaptic transmission or short-term facilitation. Our findings suggest that cognitive deficits in schizophrenia may be a consequence of hyperfunction of ErbB4 signaling leading to suppressed glutamatergic synaptic plasticity, thus opening new approaches for the treatment of this disorder.
MeSH Terms
Animals
Cognition Disorders/genetics,metabolism,physiopathology
Down-Regulation/genetics
ErbB Receptors/genetics
Hippocampus/cytology,metabolism
Long-Term Potentiation/genetics
Male
Mice
Mice, Knockout
Neural Pathways/cytology,metabolism
Organ Culture Techniques
Rats
Rats, Sprague-Dawley
Receptor, ErbB-4
Schizophrenia/genetics,metabolism,physiopathology
Synaptic Transmission/genetics
Theta Rhythm
Chemicals
ErbB Receptors
Erbb4 protein, mouse
Erbb4 protein, rat
Receptor, ErbB-4
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Pitcher Graham M
Program in Neurosciences & Mental Health, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
[email protected]
Beggs Simon
Woo Ran-Sook
Mei Lin
Salter Michael W
References (25)
25 references, click to expand
-
Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.
Am J Med Genet B Neuropsychiatr Genet. 2006 Jan 5;141B(1):96-101
PMID: 16249994
-
Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses.
J Neurosci. 2005 Oct 12;25(41):9378-83
PMID: 16221846
-
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients.
Mol Psychiatry. 2006 Feb;11(2):118-9
PMID: 16189506
-
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Nat Med. 2006 Jul;12(7):824-8
PMID: 16767099
-
Schizophrenia genes - famine to feast.
Biol Psychiatry. 2006 Jul 15;60(2):81-3
PMID: 16843093
-
Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls.
Mol Psychiatry. 2006 Dec;11(12):1062-5
PMID: 17130882
-
Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophrenia.
Dev Psychopathol. 2006 Summer;18(3):853-76
PMID: 17152404
-
Modeling of context-dependent retrieval in hippocampal region CA1: implications for cognitive function in schizophrenia.
Schizophr Res. 2007 Jan;89(1-3):177-90
PMID: 17055702
-
Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia.
Hum Mol Genet. 2007 Jan 15;16(2):129-41
PMID: 17164265
-
Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.
J Neurosci. 2007 Apr 25;27(17):4519-29
PMID: 17460065
-
The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.
Neuron. 2007 May 24;54(4):583-97
PMID: 17521571
-
Neuregulin-1 enhances depolarization-induced GABA release.
Neuron. 2007 May 24;54(4):599-610
PMID: 17521572
-
Developmental profile of neuregulin receptor ErbB4 in postnatal rat cerebral cortex and hippocampus.
Neuroscience. 2007 Aug 10;148(1):126-39
PMID: 17630218
-
The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3596-601
PMID: 10725395
-
Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses.
Neuron. 2000 May;26(2):443-55
PMID: 10839362
-
Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia.
Am J Psychiatry. 2000 Jul;157(7):1141-9
PMID: 10873924
-
ErbB transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system.
J Comp Neurol. 2001 Apr 23;433(1):86-100
PMID: 11283951
-
Theta returns.
Curr Opin Neurobiol. 2001 Dec;11(6):739-44
PMID: 11741027
-
Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences.
Cereb Cortex. 2003 Mar;13(3):252-64
PMID: 12571115
-
Cognitive experimental approaches to investigating impaired cognition in schizophrenia: a paradigm shift.
J Clin Exp Neuropsychol. 2002 Oct;24(7):873-82
PMID: 12647766
-
Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality.
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8281-6
PMID: 12824469
-
Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia.
Ann N Y Acad Sci. 2003 Nov;1003:318-27
PMID: 14684455
-
Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.
Nature. 1993 Dec 2;366(6454):473-5
PMID: 7902537
-
Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
J Med Chem. 1998 Feb 26;41(5):742-51
PMID: 9513602
-
The involvement of ErbB4 with schizophrenia: association and expression studies.
Am J Med Genet B Neuropsychiatr Genet. 2006 Mar 5;141B(2):142-8
PMID: 16402353